Miriam Kidron
2018
In 2018, Miriam Kidron earned a total compensation of $587.1K as Chief Scientific Officer and director at Oramed Pharmaceuticals, a 53% decrease compared to previous year.
Compensation breakdown
| Bonus | $46,614 |
|---|---|
| Option Awards | $253,204 |
| Salary | $273,595 |
| Other | $13,643 |
| Total | $587,056 |
Kidron received $273.6K in salary, accounting for 47% of the total pay in 2018.
Kidron also received $46.6K in bonus, $253.2K in option awards and $13.6K in other compensation.
Rankings
In 2018, Miriam Kidron's compensation ranked 11,365th out of 14,244 executives tracked by ExecPay. In other words, Kidron earned more than 20.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,365 out of 14,244 | 20th |
Division Manufacturing | 4,594 out of 5,758 | 20th |
Major group Chemicals And Allied Products | 1,738 out of 2,119 | 18th |
Industry group Drugs | 1,476 out of 1,808 | 18th |
Industry Pharmaceutical Preparations | 1,131 out of 1,382 | 18th |
Source: SEC filing on August 6, 2019.
Kidron's colleagues
We found two more compensation records of executives who worked with Miriam Kidron at Oramed Pharmaceuticals in 2018.